AAAAAA

   
Results: 1-14 |
Results: 14

Authors: WU ST ZHANG QT MARDER S
Citation: St. Wu et al., HIGH DIELECTRIC DOPANTS FOR LOW-VOLTAGE LIQUID-CRYSTAL OPERATION, JPN J A P 2, 37(10B), 1998, pp. 1254-1256

Authors: GOLDMAN RS BATES JA PAPPADOPULOS E BILDER RM BORENSTEIN M KANE J SCHOOLER N MARDER S
Citation: Rs. Goldman et al., EFFECTS OF CLOZAPINE AND HALOPERIDOL ON EXPLICIT MEMORY IN TREATMENT-REFRACTORY PATIENTS, Schizophrenia research, 24(1-2), 1997, pp. 104-104

Authors: SCHOOLER N BORENSTEIN M AMES D BAKER R UMBRICHT D WIRSHING W KANE J MARDER S
Citation: N. Schooler et al., FIRST IMPROVEMENT WITH CLOZAPINE - HOW PATIENT SHOULD WE BE, Schizophrenia research, 24(1-2), 1997, pp. 188-188

Authors: UMBRICHT D AMES D WIRSHING WC BAKER R CHENGAPPA R BORENSTEIN M SCHOOLER N MARDER S KANE J
Citation: D. Umbricht et al., PREDICTORS OF RESPONSE TO CLOZAPINE IN A LONG-TERM DOUBLE-BLIND TREATMENT STUDY, Schizophrenia research, 24(1-2), 1997, pp. 189-189

Authors: TAN ASA HSU CD MARDER S COPEL JA
Citation: Asa. Tan et al., IS MATERNAL THYROTROPIN-RELEASING-HORMONE ADMINISTRATION SAFE IN THE PREGNANT WOMAN WITH PREECLAMPSIA, American journal of perinatology, 14(1), 1997, pp. 5-6

Authors: EDSON R LAVORI P TRACY K ADLER LA ROTROSEN J GOWDA S MUKHERJEE S WILLIAMS B DUNCAN E VAID G SCHWARTZ M HITZEMANN R FRECSKA E MANICONE P CAROFF S CAMPBELL EC HAVEY J CASEY D HOFFMAN W HANSEN T BRUNDAGE T HIXS M HANNA M LOHR J BROWNING J KANOF P FAIN R KRYSTAL J DSOUZA DC DAMON D MARDER S AMES D ROSS D DOORACK J ADLER L ROTROSEN J HITZEMANN R LOHR J HAAKENSON C MILLER M
Citation: R. Edson et al., INTERRATER RELIABILITY ISSUES IN MULTICENTER TRIALS .2. STATISTICAL PROCEDURES USED IN DEPARTMENT-OF-VETERANS-AFFAIRS COOPERATIVE STUDY NUMBER-3941, Psychopharmacology bulletin, 33(1), 1997, pp. 59-67

Authors: VANKAMMEN DP MCEVOY JP TARGUM SD KARDATZKE D SEBREE TB ANDORN A BAKER RW SCHOOLER NR BORISON RL CASEY D ERESHEFSKY L FUNDERBERG L HAMNER M KARSON C MARDER S MCKINNEY W SMALL JG TAMMINGA C TUASON V VOLAVKA J CHUNG L
Citation: Dp. Vankammen et al., A RANDOMIZED, CONTROLLED, DOSE-RANGING TRIAL OF SERTINDOLE IN PATIENTS WITH SCHIZOPHRENIA, Psychopharmacology, 124(1-2), 1996, pp. 168-175

Authors: KANE JM SCHOOLER NR MARDER S WIRSHING W AMES D UMBRICHT D SAFFERMAN A BAKER R GANGULI R
Citation: Jm. Kane et al., EFFICACY OF CLOZAPINE VERSUS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL, Schizophrenia research, 18(2-3), 1996, pp. 9-9

Authors: GOLDMAN RS BATES JA BILDER RM KANE J SCHOOLER N MARDER S
Citation: Rs. Goldman et al., THE EFFECTS OF CLOZAPINE AND HALDOL ON MEMORY FUNCTIONING IN TREATMENT-REFRACTORY SCHIZOPHRENICS, Schizophrenia research, 18(2-3), 1996, p.

Authors: GAEBEL W MARDER S
Citation: W. Gaebel et S. Marder, THE ACUTE EPISODE IN SCHIZOPHRENIA - DIAGNOSIS, PROGNOSIS AND TREATMENT - PROCEEDINGS FROM A LUNDBECK-SYMPOSIUM HELD IN COPENHAGEN, 9-10 FEBRUARY 1996 - INTRODUCTION, International clinical psychopharmacology, 11, 1996, pp. 1-1

Authors: GAEBEL W MARDER S
Citation: W. Gaebel et S. Marder, CONCLUSIONS AND TREATMENT RECOMMENDATIONS FOR THE ACUTE EPISODE IN SCHIZOPHRENIA, International clinical psychopharmacology, 11, 1996, pp. 93-100

Authors: KRAMER M ZIMBROFF D LAST B GETSON A HAFEZ H ALPERT M ROTROSEN J MCEVOY J KANE J MERIDETH C SILVA A ERESHEFSKY L MARDER S CONLEY R ALLAN E KRONIG M AMES D WIRSHING W CHAVEZENG C CHENG HY REINES S
Citation: M. Kramer et al., THE EFFECTS OF A SELECTIVE D-4 ANTAGONIST (L-745,870) IN ACUTELY PSYCHOTIC SCHIZOPHRENIC-PATIENTS, Psychopharmacology bulletin, 32(3), 1996, pp. 467-467

Authors: MARDER S
Citation: S. Marder, DEFINING AND CHARACTERIZING TREATMENT-RESISTANT SCHIZOPHRENIA, European psychiatry, 10, 1995, pp. 7-10

Authors: SCHOOLER N KANE J MARDER S BAKER R SAFFERMAN A WIRSHING W AMES D GANGULI R UMBRICHT D BORENSTEIN M
Citation: N. Schooler et al., EFFICACY OF CLOZAPINE VS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL - PRELIMINARY FINDINGS, Schizophrenia research, 15(1-2), 1995, pp. 165-165
Risultati: 1-14 |